iHuman (IH) Stock Price, News & Analysis

Company Overview

iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

Key Stats

• Today's Range: $2.77 to $2.93
• 50-Day Range: $2.24 to $3.16
• 52-Week Range: $1.47 to $3.60
• Volume: 26,058 shs
• Average Volume: 62,196 shs
• Market Capitalization: $146.90 million
• P/E Ratio: 10.46
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iHuman Stock Analysis - MarketRank™

iHuman scored higher than 24% of companies evaluated by MarketBeat, and ranked 245th out of 285 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iHuman.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iHuman is 10.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of iHuman is 10.46, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 19.84.

Price to Book Value per Share Ratio

iHuman has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of iHuman have been sold short.

Short Interest Ratio / Days to Cover

iHuman has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iHuman has recently decreased by 82.11%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iHuman does not currently pay a dividend.

Dividend Growth

iHuman does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of iHuman have been sold short.

Short Interest Ratio / Days to Cover

iHuman has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iHuman has recently decreased by 82.11%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for iHuman this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iHuman insiders have not sold or bought any company stock.

Percentage Held by Insiders

63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 4.92% of the stock of iHuman is held by institutions.

IH Stock Analysis - Frequently Asked Questions

How have IH shares performed this year?

iHuman's stock was trading at $1.69 at the beginning of the year. Since then, IH shares have increased by 67.1% and is now trading at $2.8240.

How were iHuman's earnings last quarter?

iHuman Inc. Sponsored ADR (NYSE:IH) released its earnings results on Thursday, June, 26th. The company reported $0.07 earnings per share for the quarter. The firm earned $29 million during the quarter. iHuman had a trailing twelve-month return on equity of 11.00% and a net margin of 11.44%.

When did iHuman IPO?

iHuman (IH) raised $84 million in an initial public offering (IPO) on Friday, October 9th 2020. The company issued 7,000,000 shares at a price of $11.00-$13.00 per share. Credit Suisse and Citigroup served as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers.

How do I buy shares of iHuman?

Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iHuman own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iHuman investors own include Chevron (CVX), Baidu (BIDU), Tencent Music Entertainment Group (TME), Alibaba Group (BABA), Exxon Mobil (XOM), Abbott Laboratories (ABT) and JD.com (JD).

Company Calendar

• Record date for 5/15 Dividend: 4/17/2025
• Ex-Dividend for 5/15 Dividend: 4/17/2025
• Dividend Payable: 5/15/2025
• Last Earnings: 6/26/2025
• Today: 8/09/2025
• Next Earnings (Estimated): 9/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: SCHOOLS
• Sub-Industry: Personal Services
• Current Symbol: NYSE:IH
• CIK: 1814423
• Web: www.ihuman.com
• Phone: 86-10-5780-6636
• Fax: N/A
• Employees: 1,120
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.27
• Trailing P/E Ratio: 10.46
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $13.51 million
• Net Margins: 11.44%
• Pretax Margin: 11.99%
• Return on Equity: 11.00%
• Return on Assets: 7.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.07
• Quick Ratio: 3.02

Sales & Book Value

• Annual Sales: $126.34 million
• Price / Sales: 1.16
• Cash Flow: $0.30 per share
• Price / Cash Flow: 9.47
• Book Value: $2.53 per share
• Price / Book: 1.12

Miscellaneous

• Outstanding Shares: 52,020,000
• Free Float: 18,934,000
• Market Cap: $146.90 million
• Optionable: Not Optionable
• Beta: 0.39